Invention Grant
US08741923B2 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
有权
可用于治疗多发性硬化症的恶二唑稠合杂环衍生物
- Patent Title: Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
- Patent Title (中): 可用于治疗多发性硬化症的恶二唑稠合杂环衍生物
-
Application No.: US13130411Application Date: 2009-12-15
-
Publication No.: US08741923B2Publication Date: 2014-06-03
- Inventor: Mathilde Muzerelle , Anna Quattropani , Cyril Montagne , Jérôme Dorbais
- Applicant: Mathilde Muzerelle , Anna Quattropani , Cyril Montagne , Jérôme Dorbais
- Applicant Address: CH Coinsins, Vaud
- Assignee: Merck Serono SA
- Current Assignee: Merck Serono SA
- Current Assignee Address: CH Coinsins, Vaud
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP08172177 20081218
- International Application: PCT/EP2009/067171 WO 20091215
- International Announcement: WO2010/069949 WO 20100624
- Main IPC: A61K31/4245
- IPC: A61K31/4245 ; A61K31/4725 ; C07D413/14 ; C07D413/10
Abstract:
The invention provides compounds of Formula (I) for the treatment of multiple sclerosis and other diseases.
Public/Granted literature
- US20110230518A1 OXADIAZOLE FUSED HETEROCYCLIC DERIVATIVES USEFUL FOR THE TREATMENT OF MULTIPLE SCLEROSIS Public/Granted day:2011-09-22
Information query
